What is Triveni Bio worth?
$310.0Mlast known valuation
Triveni Bio last raised $115.0M in its Later Stage VC (Series B) (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Triveni Bio
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC (Series B) | $115.0M | ▮ | ▮ |
| Oct 2023 | Early Stage VC (Series A) | $91.6M | ▮ | ▮ |
How Triveni Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Triveni Bio, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Triveni Bio worth?
- Triveni Bio's implied valuation is $310.0M, based on the PA Mark composite price of about $1 per share as of Sep 2026.
- How much has Triveni Bio raised?
- Triveni Bio has raised $231.6M in total funding across 2 recorded rounds.
- When did Triveni Bio last raise?
- Triveni Bio last raised in Jun 2025 (Later Stage VC (Series B)), raising $115.0M.